Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Hip Osteoarthritis
2025-521435-36-01Phase 4Authorised
- Sponsor
- Martina Hansens Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hip osteoarthritis comparing Zoledronic acid with Placebo (2 arms). Planned start May 2025; status: authorised.
02
Drugs
zoledronic acid
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on 2025-521435-36-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521435-36-01.